Skip to main content
Figure 2 | Cancer Imaging

Figure 2

From: Contrast-enhanced [18 F] fluorodeoxyglucose-positron emission tomography/computed tomography in clinical oncology: tumor-, site-, and question-based comparison with standard positron emission tomography/computed tomography

Figure 2

A 54-year-old female patient previously submitted for surgical treatment for primary colon cancer and with a known, single liver metastasis. This patient underwent contrast-enhanced PET/CT for the exclusion of other metastatic lesions, as she was a candidate for surgical resection of the hepatic localization. (a) Axial, contrast-enhanced, full-dose CT shows a suspicious 8-mm solid lesion close to the small bowel. (b) The lesion is highly FDG-avid on contrast-enhanced PET/CT. However, the pathologic nature of this finding is clearly evident only on contrast-enhanced CT, whereas using standard CT, it could have been deemed as unspecific bowel FDG-activity. This patient thus avoided inappropriate surgical treatment and was referred for chemotherapy. PET, positron emission tomography; CT, computed tomography; FDG, [18 F] fluorodeoxyglucose.

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us